台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    91.0
  • 漲跌
    ▲1.0
  • 漲幅
    +1.11%
  • 成交量
    133
  • 產業
    上市 生技醫療類股
  • 352人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
旭富 (4119)籌碼相關-玉山-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/240.190.1000.0089.900.12480.04%
2024/12/130.591.3000.0090.600.52380.21%
2024/12/1200.00392.6792.50-3233-1.29%
2024/12/06196.9000.0097.0012200.45%
2024/12/02296.1500.0096.1022040.98%
2024/11/1800.00295.3096.00-2151-1.32%
2024/11/140.294.50394.7094.90-2.8142-1.96%
2024/11/1300.00196.0096.00-1136-0.73%
2024/11/120.594.28194.0094.30-0.5123-0.38%
2024/11/115.293.7000.0093.305.21124.63%
2024/10/18189.5000.0089.7011240.80%
2024/09/05187.20187.0086.5001600.00%
2024/09/0300.000.188.5088.50-0.1164-0.05%
2024/08/3000.00088.8088.400171-0.01%
2024/08/2900.00090.0088.5001720.00%
2024/08/2800.00089.8088.9001720.00%
2024/08/15189.2000.0088.8011880.53%
2024/08/1200.00190.7089.90-1203-0.49%
2024/08/0800.00190.6090.20-1204-0.49%
2024/08/0600.00190.0088.90-1218-0.46%
2024/08/05186.0000.0086.6012140.47%
2024/07/3000.002690.1191.00-26204-12.71%
2024/07/2200.000.190.8090.80-0.1202-0.07%
2024/07/19291.500.291.9391.601.82010.90%
2024/07/182492.6500.0092.702419912.03%
2024/07/0400.00291.1591.20-2205-0.97%
2024/07/0300.001.191.3691.40-1.1206-0.55%
2024/07/0200.00291.3091.20-2206-0.97%
2024/07/01089.7000.0089.9002030.01%
2024/06/270.190.20190.2090.10-0.9204-0.45%
2024/06/26091.6000.0090.5002030.00%
2024/06/2100.007.690.2190.30-7.6206-3.70%
2024/06/20090.3000.0090.2002060.01%
2024/06/17091.1000.0090.8002080.01%
2024/06/120.290.7000.0090.400.22110.08%
2024/06/11091.0000.0090.2002140.01%
2024/06/07093.0000.0093.1002160.01%
2024/05/31092.4000.0092.0002300.01%
2024/05/290.292.5000.0092.300.22340.06%
2024/05/2800.001.192.7192.50-1.1235-0.48%
2024/05/2300.00191.5091.30-1235-0.42%
2024/05/2100.00392.8092.10-3235-1.27%
2024/05/17093.9000.0093.9002300.01%
2024/05/130.391.70391.7791.80-2.8232-1.18%
2024/05/10190.70190.5090.9002400.00%
2024/05/07088.3000.0088.1002420.01%
2024/05/06088.7000.0088.5002420.01%
2024/05/03088.9500.0088.5002420.01%
2024/05/02089.0000.0088.8002440.01%
2024/04/30089.0000.0089.0002450.01%
2024/04/29089.0000.0089.2002460.01%
2024/04/26188.800.188.8089.000.92450.37%
2024/04/2500.00088.7388.500245-0.01%
2024/04/2400.00088.8087.8002450.00%
2024/04/230.187.50187.6087.80-0.9252-0.36%
2024/04/22086.4000.0086.5002540.00%
2024/04/193.186.8100.0086.403.12541.20%
2024/04/17188.4900.0088.4012490.40%
2024/04/15088.0200.0087.7002520.01%
2024/04/120.188.8000.0088.500.12530.02%
2024/04/110.189.0000.0088.900.12610.04%
2024/04/030.188.460.288.4087.80-0.1258-0.05%
2024/04/020.189.3000.0088.600.12590.04%
2024/03/2900.00089.0088.400258-0.01%
2024/03/281.188.3000.0088.301.12580.41%
2024/03/270.188.40288.1087.50-2259-0.75%
2024/03/26187.2300.0087.2012600.40%
2024/03/25088.2000.0087.6002610.01%
2024/03/22087.6500.0087.6002650.01%
2024/03/21087.8300.0087.7002740.01%
2024/03/20187.7000.0087.6012780.36%
2024/03/19287.95188.4087.9012800.35%
2024/03/18186.8100.0086.9012840.36%
2024/03/15088.0000.0087.4002850.01%
2024/03/14087.4100.0087.2002860.01%
2024/03/13088.5000.0087.9002850.01%
2024/03/12089.3900.0089.0002780.01%
2024/03/11189.2100.0089.1012750.37%
2024/03/083.192.7400.0090.403.12731.12%
2024/03/07189.9100.0090.5012690.38%
2024/03/06390.8000.0090.9032701.12%
2024/03/05091.8000.0090.9002740.01%
2024/03/04091.1500.0090.9002740.01%
2024/03/01091.9500.0091.4002740.01%
2024/02/29091.5900.0091.2002810.01%
2024/02/27091.930.192.5091.5002810.00%
2024/02/260.191.7000.0092.100.12830.02%
2024/02/2300.00191.3091.10-1283-0.35%
2024/02/16190.8000.0090.6012850.35%
2024/02/15189.4000.0089.9012930.34%
2024/02/0500.00091.0091.100291-0.01%
2024/02/02190.0000.0090.8012900.34%
2024/02/01191.9000.0092.3012990.33%
2024/01/1600.00196.3096.10-1308-0.32%
2024/01/0500.00299.65100.00-2317-0.63%
2024/01/0400.00298.5098.50-2309-0.65%
2024/01/0300.000.598.0098.00-0.5311-0.17%
2024/01/0200.00397.5098.30-3315-0.95%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章